Ensign Peak Advisors, Inc
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1454984
SALT LAKE CITY, UT
Position in REGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$29,943,637
+$15,223,300 QoQ
Shares Held
48,022
+152.1% QoQ
Ownership
0.047%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#164
of 1,322 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ensign Peak Advisors, Inc holds $1,111,483,806 across 123 Biotechnology names. REGN ranks #11 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
210,483 | $104,553,220 | |
| 2 | INSM |
INSMED Inc
|
702,951 | $74,948,635 | |
| 3 | ABVX |
Abivax S.A.
|
504,471 | $67,225,805 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
760,977 | $56,677,566 | |
| 5 | ARGX |
Argenx SE
|
52,027 | $48,269,089 | |
| 6 | PTCT |
Ptc Therapeutics, Inc.
|
508,056 | $41,442,127 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
591,815 | $33,621,010 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
579,052 | $31,847,860 |
All Filings in REGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $29,943,637 | 48,022 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $14,720,337 | 19,052 | Shares | Sole | 2026-08-18 | |
| 2025-12-31 | $11,461,497 | 14,849 | Shares | Sole | 2026-08-18 | |
| 2025-09-30 | $17,522,020 | 31,163 | Shares | Sole | 2026-08-18 | |
| 2025-06-30 | $13,008,450 | 24,778 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $27,700,629 | 43,676 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $29,667,832 | 41,649 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $44,932,100 | 42,742 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $135,279,122 | 128,711 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $128,186,343 | 133,182 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $122,210,540 | 139,146 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $105,055,781 | 127,656 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $89,568,166 | 124,653 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $39,899,473 | 48,559 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $36,692,816 | 50,857 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $34,876,799 | 50,629 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $35,529,277 | 60,104 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $31,917,095 | 45,699 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $35,505,948 | 56,223 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $54,398,419 | 89,888 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $54,780,486 | 98,078 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $48,419,255 | 102,336 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $66,446,466 | 137,539 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $84,656,089 | 151,231 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $97,038,069 | 155,597 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $41,609,632 | 85,215 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||